RFK Jr. Set for Senate Hearings with Four GOP Doctors
On April 21, 2026, Robert F. Kennedy Jr. will participate in Senate hearings alongside four Republican doctors, with a focus on his interactions with Bill Cassidy.
Editorial Staff Apr 21
Health
Latest Health stories from Life.
The Challenges of Using the 25th Amendment for Trump's Removal
In a recent opinion piece, Lawrence K. Altman argues that efforts to invoke the 25th Amendment for Trump's removal are misguided, providing insights into the complexities involved.
Editorial Staff Apr 21
Purdue Pharma's $225 Million Forfeiture Paves the Way for Settlement Finalization
A judge is anticipated to impose a $225 million forfeiture on Purdue Pharma, the maker of OxyContin, facilitating the completion of its settlement with the Justice Department.
Editorial Staff Apr 21
Kelonia Therapeutics Transforms from Struggles to a $3 Billion Valuation
The biotech sector sees notable developments as Kelonia Therapeutics rebounds significantly, while BioAge focuses on inflammation and other industry updates emerge.
Editorial Staff Apr 21
Purdue Pharma to Forfeit $225 Million in Settlement with Justice Department
A U.S. judge is anticipated to order Purdue Pharma to forfeit $225 million, marking a significant step in ongoing legal proceedings.
Editorial Staff Apr 21
Changes to CDC Conference Accessibility Raise Concerns
Recent developments indicate that a CDC conference, previously open to the public, may now have restricted access. This follows a federal ruling related to gender declaration and highlights ongoing issues in health policy.
Editorial Staff Apr 21
BioAge Labs Reports Early Success with Pill Targeting Heart Risk Inflammation
BioAge Labs has announced encouraging findings from an early study of its investigational pill designed to reduce cardiovascular risks by targeting inflammation.
Editorial Staff Apr 21
Tortugas Neuroscience Emerges with Ambitious Drug Development Goals
Tortugas Neuroscience has officially launched, aiming to develop new treatments for brain disorders by leveraging licenses from Jiangsu Hansoh and Eisai.
Editorial Staff Apr 21
KFF Launches New Podcast to Navigate Health Policy and Business
KFF is set to debut a podcast hosted by Chip Kahn, focusing on the intricate relationship between health policy and business. The initiative aims to deepen understanding of these complexities.
Editorial Staff Apr 21
Rethinking the U.S. Health Care System: A Look Backward
The current U.S. health care system appears to prioritize retrospective evaluations, questioning the justification of past medical decisions.
Editorial Staff Apr 21
The Implications of Executive Dysfunction in Leadership Roles
The presence of executive dysfunction in a CEO can lead to considerable challenges for an organization, raising questions about leadership effectiveness.
Editorial Staff Apr 21
Examining the Impact of Trump's Executive Actions on LGBTQ+ Health
This analysis explores the Executive Actions from the Trump administration that may affect the health of LGBTQ+ individuals, detailing their potential implications.
Editorial Staff Apr 21
Exploring Innovative CAR-T Applications at AACR: Implications for Multiple Myeloma
The recent AACR conference highlighted a daring application of CAR-T therapy, sparking discussions about its potential in treating smoldering multiple myeloma.
Editorial Staff Apr 20
Pfizer's Chief Strategy Officer Andrew Baum Resigns Amid Strategic Overhaul
Andrew Baum, who previously served as Pfizer's executive vice president and chief strategy and innovation officer, has stepped down from his position.
Editorial Staff Apr 20
Promising CAR-T Trial Offers Hope for High-Risk Multiple Myeloma Patients
Recent findings from a CAR-T trial suggest potential in preventing smoldering multiple myeloma from progressing to active disease in high-risk individuals.
Editorial Staff Apr 20
Trump's Executive Order on Psychedelics: A Double-Edged Sword
While President Trump's executive order to advance psychedelic treatments has garnered enthusiasm from advocates, it also raises concerns about potential politicization and credibility issues.
Editorial Staff Apr 20
Exploring the Paradox in Republican Support for Psychedelics
Dimitri Mugianis and Ross Ellenhorn argue that while Republicans are increasingly supporting psychedelics, the essence of recovery transcends mere medication.
Editorial Staff Apr 20
Barriers to Health Insurance for Lower-Wage Workers Persist
Despite health insurance accounting for 8% of total employee compensation, lower-wage workers continue to face significant challenges in accessing coverage.
Editorial Staff Apr 20
Eli Lilly Acquires Kelonia Therapeutics for $3.25 Billion After Challenging Journey
The acquisition of Kelonia Therapeutics by Eli Lilly for $3.25 billion marks a significant turn for the struggling biotech firm, which faced numerous challenges.
Editorial Staff Apr 20
Understanding the Ongoing Battle Over Drug Price Transparency
A closer look at the ongoing disputes surrounding drug price transparency and the role of pharmacy benefit managers (PBMs) in this contentious issue.
Editorial Staff Apr 20